Endogenous nitric oxide in Pseudomonas fluorescens ZY2 as mediator against the combined exposure to zinc and cefradine.
- Published in:
- Ecotoxicology, 2015, v. 24, n. 4, p. 835, doi. 10.1007/s10646-015-1428-6
- By:
- Publication type:
- Article
Works by Yuan, Bao‐Hong
Results: 6
1
2
Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy.
- Published in:
- PLoS ONE, 2017, v. 12, n. 3, p. 1, doi. 10.1371/journal.pone.0174222
- By:
- Publication type:
- Article
3
lncSNHG16 promotes hepatocellular carcinoma development by inhibiting autophagy.
- Published in:
- Clinical & Translational Oncology, 2025, v. 27, n. 4, p. 1612, doi. 10.1007/s12094-024-03730-y
- By:
- Publication type:
- Article
4
Repeat hepatic resection versus percutaneous ablation for the treatment of recurrent hepatocellular carcinoma: meta-analysis.
- Published in:
- BJS Open, 2022, v. 6, n. 2, p. 1, doi. 10.1093/bjsopen/zrac036
- By:
- Publication type:
- Article
5
Letter: is tenofovir superior to entecavir for hepatocellular carcinoma prevention in chronic hepatitis B?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 2, p. 314, doi. 10.1111/apt.15603
- By:
- Publication type:
- Article
6
Lower risk of hepatocellular carcinoma with tenofovir than entecavir treatment in subsets of chronic hepatitis B patients: an updated meta‐analysis.
- Published in:
- Journal of Gastroenterology & Hepatology, 2022, v. 37, n. 5, p. 782, doi. 10.1111/jgh.15783
- By:
- Publication type:
- Article